Information Provided By: 
Fly News Breaks for May 11, 2017
ICUI
May 11, 2017 | 10:03 EDT
As previously reported, Roth Capital analyst Chris Lewis downgraded ICU Medical to Neutral from Buy, citing the potential for speedbumps as its Hospira Infusion Systems integration continues and the stock's current "heightened" valuation. Lewis raised his price target on ICU Medical, however, to $172 from $165.
News For ICUI From the Last 2 Days
There are no results for your query ICUI
